Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0042963 (vomiting)
 31,883 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

148 newborns of non-atopic and 329 newborns of atopic parents were included in a five-year follow-up study of atopic diseases. The prevalence of atopic diseases at five years of age is compared to environmental factors, which may be involved in the development of atopic diseases. There was no significant correlation between the development of atopic disease and the following factors: the nature of the immediate environment (industrial, agricultural, rural, urban, arboreal, lake-district); building materials, heating systems and general state of repair of the houses, including its interior decoration; the presence of pets, plants, humidifiers or cigarette smoke. There was, however, one exception: in both family groups the avoidance of woollen garments and bed clothes before the outbreak of atopic symptoms was associated with the increased prevalence of asthma, allergic rhinitis and atopic dermatitis. The cause of this association remained uncertain. Children with atopic diathesis are known to frequently display skin intolerance to wool. Therefore, wool avoidance in a family may only indicate that the child was potentially atopic. Atopic children suffered from ear infections and vomiting more often than control children. The incidence of ear infections was also increased amongst children with a positive family history of atopy, even if no atopic disease was diagnosed in the child himself. Although breast fed infants tended to have less infectious diseases than those weaned early, ear infections were equally common in all feeding groups. This is further evidence, that in part of the cases of recurrent ear infections, atopy should be considered as a possible etiologic factor.
 ...
PMID:Environmental allergens and morbidity in atopic and non-atopic families. 646 33

Data from 34 patients were included in the analysis of this open group comparative study comparing a controlled release theophylline given twice daily with immediate release aminophylline given four times daily. The treatment period was of eight weeks duration. There was no significant difference between treatments in clinical assessments of asthma severity or pulmonary function tests. Similarly there were no significant differences between treatments in diary card assessments of asthma symptoms or PERF. Serum theophylline levels were measured prior to the morning dose of test treatment and 2 or 5 hours later, respectively for patients taking immediate release (IR) or controlled release (CR) preparations, at each clinic visit. There was no significant difference between treatments in serum theophylline levels fluctuations, although the dosing interval (12 hours) was twice as long for CR formulation. Six patients reported unusual symptoms, two in the CR group (headache, gastric discomfort) four in the aminophylline group (three headache, one headache and vomiting).
 ...
PMID:[Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation]. 653 26

Attention is called to vomiting as a major manifestation of asthma. The diagnosis requires only careful history and examination. Symptoms respond well to therapy for asthma. Asthma should be included in the differential diagnosis of recurrent or severe vomiting. If this is done, unnecessary diagnostic procedures can be avoided and proper therapy can be promptly instituted.
 ...
PMID:The vomiting asthmatic. 674 24

One case of a para-oesophageal hernia and ten cases of gasto-oesophageal reflux with or without hiatal hernia are reviewed. Vomiting commenced from the first week of life and in three children progressed to stricture formation. Pulmonary manifestations of gastro-oesophagela reflux were intractable asthma and attacks of bronchiolitis. A surgical operation performed through the abdomen was successful in controlling the reflux in all cases. Follow-up barium studies in all cases showed no hernia recurrences. A conservative approach to fibrous reflux strictures has been adopted and it is found that these can be cured by dilatations once the reflux has been controlled.
 ...
PMID:Gastro-oesophageal reflux and hiatal hernia in children. 693 48

The efficacy of metaproterenol (orciprenaline) and theophylline given orally at currently recommended doses was examined in 34 children with chronic asthma using a randomized double-blind cross-over evaluation of four weeks' duration for each active regimen. No serious adverse effects were seen with either medication, but tremor occurred more frequently with metaproterenol (P less than 0.01). No significant differences were observed in the frequency of nausea, vomiting, headache, or insomnia (P greater than 0.05). Symptoms of wheezing, coughing, exercise intolerance, and interference with sleep were more frequently associated with the oral metaproterenol regimen; completely asymptomatic days occurred 50% more frequently in association with theophylline therapy (P less than 0.01). Mean peak flows, performed twice daily during each of the four-week study periods, were 86 and 92% of predicted for metaproterenol and theophylline, respectively (P less than 0.05). Pulmonary function decreased significantly less with theophylline than with metaproterenol among those who completed six minutes of treadmill exercise during both regimens (P less than 0.05). Corticosteroids, used for acute symptoms that failed to respond to the addition of inhaled metaproterenol, were required in four patients during both regimens, in ten patients only during the metaproterenol regimen, and in one patient only during the theophylline regimen (P less than 0.02). Thus, theophylline therapy was associated with fewer adverse effects, fewer symptoms of asthma, better pulmonary function, better exercise tolerance, and less requirements for corticosteroids than was treatment with metaproterenol.
 ...
PMID:Comparison of orally administered metaproterenol and theophylline in the control of chronic asthma. 704 7

During the 1980 influenza B outbreak in King County, Washington, 11 children whose asthma had previously been controlled with a stable theophylline dose, developed theophylline toxicity on this same dose. Two had seizures, eight had nausea and vomiting, and three had headaches. All had clinical evidence of a febrile viral illness. The toxicity appeared to be related to decreased theophylline clearance, which gradually returned to preillness levels over a period of one to three months. Six of ten children had serologic evidence of influenza B, which is presumed to be the cause of the altered clearance. In children receiving chronic theophylline therapy, symptoms of vomiting, headaches, or seizures during a viral illness may be due to theophylline toxicity rather than the virus. Such patients should have an immediate serum theophylline determination, even if previous levels have been in the therapeutic range.
 ...
PMID:Altered theophylline clearance during an influenza B outbreak. 707 Aug 95

Gastroesophageal reflux in infants and children is a complex disease. The diagnosis in 14 operative patients was made utilizing a careful history, barium swallow, technetium radionuclide milk scan, and endoscopy with esophageal biopsy. Symptoms were intractable vomiting, failure to thrive, recurrent pneumonia, apnea, asthma and bronchitis, esophagitis, and esophageal stricture. The pernicious aspects of this disease include a potentially significant mortality in children with severe apnea episodes, increased morbidity with esophagitis, and psychosocial disruption for those children that progress to the teenage years with recurrent vomiting, rumination, heartburn and stricture formation. A high incidence of gastroesophageal reflux unresponsive to medical management was noted with esophageal atresia and neurologic disease. The Nissen fundoplication was used in all patients and proved an effective procedure with a low morbidity and recurrence rate.
 ...
PMID:Gastroesophageal reflux in children: an underrated disease. 707 8

"Spontaneous" rupture of the oesophagus is rare and happens after a marked rapid rise in intraluminal oesophageal pressure (massive vomiting, asthma etc.). As is known from the literature, forceful swallowing alone may produce spontaneous perforation in the case of damage to the mucosa or muscular layer of the oesophagus. Boerhaave's syndrome associated with rare diffuse idiopathic muscular hypertrophy of the lower oesophagus has been described in only three cases in the literature.
 ...
PMID:[Spontaneous perforation of the esophagus (Boerhaave syndrome) in diffuse idiopathic muscular hypertrophy]. 707 11

Allergic reactions to food colors have been known since 1958. Reactions to tartrazine, our example, include generalized pruritus, urticaria, angioedema, paresthesias, vomiting, migraine, rhinorrhea and nasal obstruction, coughing, asthma attacks and purpura. Many patients who are allergic to antiinflammatory drugs such as acetyl-salicylic acid and indomethacin show cross-reaction to tartrazine. Doses producing these reactions range from minimal amounts up to 750 mg. Symptoms appear after periods of time ranging from minutes to 6 to 14 hours. In view of these facts (some of which represent a threat to the patient's life), additives, colouring matter, etc, do not usually appear in product labels or specifications, or in handbooks or catalogues used in practice. We drew up a list of drugs which may contain food dyes and coloring matter, yellow No. 5. A letter was written to 233 laboratories of which 159 (68%) replied. 72 (45%) in the affirmative and 87 (55%) in the negative, 74 (32%) did not reply.
 ...
PMID:[Pharmaceutical preparations which contain tartrazine]. 725 46

Sumatriptan is a potent and selective agonist at a vascular serotonin1 (5-hydroxytryptamine1; 5-HT1) receptor subtype (similar to 5-HT1D) and is used in acute treatment of migraine and cluster headache. Following administration of sumatriptan 100mg orally, relief of migraine headache (at 2 hours) was achieved in 50 to 67% of patients compared with 10 to 31% with placebo in controlled clinical trials. In a comparative study, oral administration of sumatriptan 100mg consistently achieved significantly greater response rates than a fixed combination of ergotamine 2mg plus caffeine 200mg during 3 consecutive migraine attacks (66 vs 48% for first attack). Oral sumatriptan 100mg was also more effective than aspirin 900mg plus metoclopramide 10mg orally in a similar study. In the majority of controlled clinical trials, headache relief (at 1 hour after administration) was achieved in 70 to 80% of patients with migraine receiving sumatriptan 6mg subcutaneously compared with 18 to 26% of placebo recipients. Approximately 40% of patients who initially responded to oral or subcutaneous sumatriptan experienced recurrence of their headache, usually within 24 hours, but the majority of these patients responded well to a further dose of sumatriptan. Patients with cluster headache were treated for acute attacks with sumatriptan 6mg subcutaneously or placebo in 2 crossover trials. Headache relief was achieved within 15 minutes in 74 and 75% of patients receiving sumatriptan in these studies compared with 26 and 35%, respectively, with placebo. Patients receiving sumatriptan 12mg had a similar response rate as those receiving 6mg, but the higher dose was associated with an increased incidence of adverse events. Based on extensive safety data pooled from controlled clinical trials, sumatriptan is generally well tolerated and most adverse events are transient. The most frequently reported adverse events following oral administration include nausea, vomiting, malaise, fatigue and dizziness. Injection site reactions (minor pain and redness of brief duration) occur in approximately 40% of patients receiving subcutaneous sumatriptan, although the incidence appears to be markedly reduced when patients self-administer the drug with an auto-injector. Chest symptoms (mainly tightness and pressure) occur in 3 to 5% of sumatriptan recipients, but have not been associated with myocardial ischaemia except in a few isolated cases. Sumatriptan is contraindicated in patients with ischaemic heart disease, angina pectoris including Prinzmetal (variant) angina, previous myocardial infarction and uncontrolled hypertension, but is not contraindicated in patients with migraine and asthma. Data from long term studies in acute treatment of migraine and cluster headache suggest that sumatriptan remains effective and well tolerated over several months.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. 751 61


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>